GLFD Guilford Pharmaceuticals (MM)

Guilford Pharmaceuticals to Announce Third Quarter 2004 Financial Results on Monday, November 8, 2004 BALTIMORE, Nov. 5 /PRNewswire-FirstCall/ -- Guilford Pharmaceuticals Inc. (NASDAQ:GLFD) will announce its third quarter 2004 financial results on Monday, November 8, 2004 and will also host a conference call and live audio webcast beginning at 4:00 p.m. E.T. The press release and live webcast can be accessed by going to the Investor Relations section of Guilford's website at http://www.guilfordpharm.com/. Following the webcast, an archived version of the call will be available until Monday, November 22, 2004. To participate in the live conference call, U.S. residents should dial 800-299-7928, international callers 617-614-3926. The participant passcode is 68168189. An audio replay of the conference call will be available for 72 hours beginning at approximately 6:00 p.m. E.T. on November 8, 2004 through 6:00 p.m. November 11, 2004. To access the replay, U.S. residents should dial 888-286-8010, (int'l callers 617-801-6888), passcode 45654677. Guilford Pharmaceuticals Inc. is a pharmaceutical company engaged in the research, development and commercialization of products that target the hospital market. Presently, Guilford markets two commercial products, GLIADEL(R) Wafer (polifeprosan 20 with carmustine implant), for the treatment of brain cancer, and AGGRASTAT(R) Injection (tirofiban hydrochloride), a glycoprotein GP IIb/IIIa receptor antagonist used for the treatment of acute coronary syndrome (ACS). Guilford's product pipeline includes a novel anesthetic, AQUAVAN(R) Injection. For additional information about GLIADEL(R) Wafer, please visit http://www.gliadel.com/; and for AGGRASTAT(R) Injection, please see http://www.aggrastat.com/. CONTACT: Stacey Jurchison, Guilford Pharmaceuticals Inc., +1-410-631-5022, DATASOURCE: Guilford Pharmaceuticals Inc. CONTACT: Stacey Jurchison, Guilford Pharmaceuticals Inc., +1-410-631-5022, Web site: http://www.gliadel.com/ Web site: http://www.aggrastat.com/ Web site: http://www.guilfordpharm.com/ Company News On-Call: http://www.prnewswire.com/comp/112882.html

Copyright